Hematogenous metastasis of ovarian cancer: rethinking mode of spread (Q33908024)

29 July 2017

Hematogenous metastasis of ovarian cancer: rethinking mode of spread (English)

1 reference

Cristian Rodriguez-Aguayo

29 July 2017

1 reference

15

object named as

Cristian Rodriguez-Aguayo

1 reference

29 July 2017

4

Masato Nishimura

1 reference

29 July 2017

32

Anil K Sood

1 reference

29 July 2017

Sunila Pradeep

1

1 reference

29 July 2017

Seung W Kim

2

1 reference

29 July 2017

Sherry Y Wu

3

1 reference

29 July 2017

Pradeep Chaluvally-Raghavan

5

1 reference

29 July 2017

Takahito Miyake

6

1 reference

29 July 2017

Chad V Pecot

7

1 reference

29 July 2017

Sun-Jin Kim

8

1 reference

29 July 2017

Hyun Jin Choi

9

1 reference

29 July 2017

Farideh Z Bischoff

10

1 reference

29 July 2017

Julie Ann Mayer

11

1 reference

29 July 2017

Li Huang

12

1 reference

29 July 2017

Alpa M Nick

13

1 reference

29 July 2017

Carolyn S Hall

14

1 reference

29 July 2017

Behrouz Zand

16

1 reference

29 July 2017

Heather J Dalton

17

1 reference

29 July 2017

Thiruvengadam Arumugam

18

1 reference

29 July 2017

Ho Jeong Lee

19

1 reference

29 July 2017

Hee Dong Han

20

1 reference

29 July 2017

Min Soon Cho

21

1 reference

29 July 2017

Rajesha Rupaimoole

22

1 reference

29 July 2017

Lingegowda S Mangala

23

1 reference

29 July 2017

Vasudha Sehgal

24

1 reference

29 July 2017

Sang Cheul Oh

25

1 reference

29 July 2017

Jinsong Liu

26

1 reference

29 July 2017

Ju-Seog Lee

27

1 reference

29 July 2017

Robert L Coleman

28

1 reference

29 July 2017

Prahlad Ram

29

1 reference

29 July 2017

Gabriel Lopez-Berestein

30

1 reference

29 July 2017

Isaiah J Fidler

31

1 reference

29 July 2017

1 July 2014

1 reference

29 July 2017

1 reference

29 July 2017

26

1 reference

29 July 2017

1

1 reference

29 July 2017

77-91

1 reference

Tumour angiogenesis regulation by the miR-200 family

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Optical quantification of cellular mass, volume, and density of circulating tumor cells identified in an ovarian cancer patient

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

NetWalker: a contextual network analysis tool for functional genomics

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Paraneoplastic thrombocytosis in ovarian cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

A phase 3 trial of bevacizumab in ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

A novel platform for detection of CK+ and CK- CTCs

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Inhibition of phosphorylated c-Met in rhabdomyosarcoma cell lines by a small molecule inhibitor SU11274

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Use of data-biased random walks on graphs for the retrieval of context-specific networks from genomic data

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Regulation of tumor angiogenesis by EZH2.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

HER3 mRNA as a predictive biomarker in anticancer therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Targeted gene silencing using RGD-labeled chitosan nanoparticles

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

An ErbB3 antibody, MM-121, is active in cancers with ligand-dependent activation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Circulating monocytes expressing CD31: implications for acute and chronic angiogenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Dicer, Drosha, and outcomes in patients with ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Ovarian cancer metastasis: integrating insights from disparate model organisms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

EphA2 expression is associated with aggressive features in ovarian carcinoma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Heregulin regulates cytoskeletal reorganization and cell migration through the p21-activated kinase-1 via phosphatidylinositol-3 kinase

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

[Ovarian metastasis and lung adenocarcinoma: a case report]

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4100212

Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts

29 October 2018

1 reference

12 December 2020

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

12 December 2020

Antiangiogenic agents should be integrated into the standard treatment for patients with ovarian cancer

1 reference

12 December 2020

Relationship of estrogen and progesterone receptors to clinical outcome in metastatic endometrial carcinoma: a Gynecologic Oncology Group Study

1 reference

12 December 2020

10.1016/J.CCR.2014.05.002

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference